| Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis X Lu, ZY Zhou, Y Xin, MJ Wang, E Gray, V Jairath, JO Lindsay Inflammatory Bowel Diseases 30 (1), 64-77, 2024 | 3 | 2024 |
| CO95 A Matching-Adjusted Indirect Comparison of Filgotinib Versus Tofacitinib for Moderately to Severely Active Ulcerative Colitis X Lu, E Gray, Y Xin, J Zhou, V Jairath, JO Lindsay Value in Health 25 (7), S321, 2022 | | 2022 |
| Forget polypharmacy for type 2 diabetes! Weight management is a better investment M Lean, L McCombie, Y Xin Nephrology Dialysis Transplantation 37 (5), 844-846, 2022 | 2 | 2022 |
| From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R Y Xin, E Gray, JA Robles-Zurita, H Haghpanahan, R Heggie, ... Applied health economics and health policy, 1-10, 2022 | 4 | 2022 |
| Feasibility study for interactive reporting of network meta-analysis: experiences from the development of the MetaInsight COVID-19 app for stakeholder exploration, re-analysis … Y Xin, CR Nevill, J Nevill, E Gray, NJ Cooper, N Bradbury, AJ Sutton BMC Medical Research Methodology 22 (1), 26, 2022 | 3 | 2022 |
| Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic TJ Quinn, JK Burton, B Carter, N Cooper, K Dwan, R Field, SC Freeman, ... BMC medicine 19, 1-10, 2021 | 55 | 2021 |
| Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic TJ Quin, JK Burton, B Carter, N Cooper, K Dwan, R Field, SC Freeman, ... BMC medicine 19 (1), 207-207, 2021 | 1 | 2021 |
| Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network … Y Takaoka, T Suzuki, D Yoneoka, Y Nishikawa, WW San Tam, J Morze, ... Cochrane Database of Systematic Reviews, 2021 | 75 | 2021 |
| OP272 Two-Year Within-Trial And Estimated Lifetime Cost Effectiveness Of The Weight Management Program In The Diabetes REmission Clinical Trial (DiRECT) Y Xin, A Davies, A Briggs, L McCombie, CM Messow, E Grieve, WS Leslie, ... International Journal of Technology Assessment in Health Care 36 (S1), 4-4, 2020 | | 2020 |
| Cost-effectiveness of the PDSAFE personalised physiotherapy intervention for fall prevention in Parkinson’s: an economic evaluation alongside a randomised controlled trial Y Xin, A Ashburn, RM Pickering, KC Seymour, S Hulbert, C Fitton, ... BMC neurology 20, 1-9, 2020 | 9 | 2020 |
| Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management … Y Xin, A Davies, A Briggs, L McCombie, CM Messow, E Grieve, WS Leslie, ... Diabetologia 63, 2112-2122, 2020 | 34 | 2020 |
| Two-year within-trial and estimated lifetime cost-effectiveness of the weight management programme in the Diabetes Remission Clinical Trial (DiRECT) Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ... DIABETIC MEDICINE 37, 88-89, 2020 | | 2020 |
| MetaInsight: an interactive web‐based tool for analyzing, interrogating, and visualizing network meta‐analyses using R‐shiny and netmeta RK Owen, N Bradbury, Y Xin, N Cooper, A Sutton Research synthesis methods 10 (4), 569-581, 2019 | 181 | 2019 |
| A loyalty scheme to encourage physical activity in office workers: a cluster RCT R Hunter, A Gough, J Murray, J Tang, S Brennan, O Chrzanowski-Smith, ... Public Health Research 7 (15), 1-144, 2019 | 7 | 2019 |
| Results from the process evaluation RF Hunter, A Gough, JM Murray, J Tang, SF Brennan, ... A loyalty scheme to encourage physical activity in office workers: a cluster RCT, 2019 | | 2019 |
| Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight‐Plus weight management programme within a primary care randomized controlled trial Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ... Diabetic Medicine 36 (8), 1003-1012, 2019 | 28 | 2019 |
| Results from the mediation analyses RF Hunter, A Gough, JM Murray, J Tang, SF Brennan, ... A loyalty scheme to encourage physical activity in office workers: a cluster RCT, 2019 | | 2019 |
| Counterweight-Plus controls T2DM at low cost Y Xin PharmacoEconomics & Outcomes News 828, 11-18, 2019 | | 2019 |
| Cost of the Counterweight-Plus weight management programme to achieve diabetes remission and its one year costeffectiveness: Results from the Diabetes REmission Clinical Trial … Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ... DIABETIC MEDICINE 36, 92-92, 2019 | | 2019 |
| Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ... The lancet Diabetes & endocrinology 7 (3), 169-172, 2019 | 32 | 2019 |
